NCT06160232View on ClinicalTrials.gov

Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

December 15, 2025

Study Completion Date

June 15, 2026

Conditions
Severe Alcohol Use Disorder
Interventions
DRUG

Psilocybin (high dose)

Psilocybin-assisted therapy

DRUG

Active placebo (low dose of psilocybin)

Placebo-assisted therapy

Trial Locations (1)

Unknown

RECRUITING

Brugmann University Hospital, Brussels

All Listed Sponsors
lead

Brugmann University Hospital

OTHER